Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nuria Carrizo
Observed name:
N. Carrizo
Institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre
Observed institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre,
Centro de Investigación Biomédica en Red de Cáncer
ORCID:
0000-0002-0409-1048
Observed ORCID:
0000-0002-0409-1048
OpenAlex ID:
A5043791586
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB 2 harmonization project comparing three NGS panels
2021
·
Javier Ramos-Paradas
, Susana Hernández-Prieto
, et al.
·
Journal for ImmunoTherapy of Cancer
·
38
PDF
Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
2022
·
Javier Ramos-Paradas
, David Gómez-Sánchez
, et al.
·
Journal of Clinical Medicine
·
11
PDF
Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non–Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments
2017
·
Jon Zugazagoitia
, Daniel Rueda
, et al.
·
Clinical Lung Cancer
·
10
PD-L1, VISTA, and CD47 expression and prognosis impact in malignant pleural mesothelioma.
2022
·
Mercedes Herrera
, Álvaro C. Ucero
, et al.
·
Journal of Clinical Oncology
·
2
Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis
2021
·
Javier Ramos Paradas
, David Gomez-Sanchez
, et al.
·
European Respiratory Journal
·
1
Abstract 5247: Interleukin-11 could be a novel therapeutic target for lung adenocarcinoma patients
2020
·
Laura Ojeda
, Cristina Cirauqui
, et al.
·
Cancer Research
·
1
Harmonization study of tumour mutational burden determination in non-small cell lung cancer (NSCLC)
2019
·
E.M. Garrido-Martin
, J. Ramos-Paradas
, et al.
·
Annals of Oncology
·
1
PDF
Context-dependent value of HLA class I diversity in advanced non-small cell lung cancer treated with immune checkpoint blockade
2026
·
Javier Ramos-Paradas
, Nuria Carrizo
, et al.
·
Frontiers in Immunology
PDF
Abstract 6562: Identifying vulnerabilities to immune checkpoint inhibitors of oncogene-addicted non-small cell lung cancer subgroups
2026
·
Inés Díaz-Cano
, José Gracia
, et al.
·
Cancer Research
Digital spatial profiling for identification of prognostic genes and molecular subgroups in pleural mesothelioma.
2025
·
Mercedes Herrera
, David Lora
, et al.
·
Journal of Clinical Oncology
PDF
Abstract 910: Chromosome 3q amplification in lung squamous cell carcinoma is associated to iron metabolism and immune cell exclusion
2025
·
María Gutiérrez Pérez
, Javier Ramos Paradas
, et al.
·
Cancer Research
Abstract 5801: Identifying vulnerabilities to immune checkpoint inhibitors of oncogene-addicted non-small cell lung cancer subgroups
2025
·
Inés Díaz-Cano
, José Gracia
, et al.
·
Cancer Research
Abstract 7422: Enabling biomarkers of chromosomal instability for tumor only targeted gene panel sequencing
2024
·
David Gómez-Sánchez
, Joe Sneath Thompson
, et al.
·
Cancer Research
1280P Comprehensive characterization of human lung squamous cell carcinoma identifies high TFRC expression as a mark of poorly immunogenic tumours
2023
·
M. Gutiérrez Pérez
, J. Ramos Paradas
, et al.
·
Annals of Oncology
PDF
Abstract 1245: Comprehensive analysis of non-small cell lung cancer identifies molecular genotype-immunophenotype associations and candidate biomarkers predictive of response to immunotherapy
2022
·
Javier Ramos-Paradas
, David Gomez-Sanchez
, et al.
·
Cancer Research
Abstract 3101: Evaluation of novel therapeutic strategies for KRAS mutated NSCLC patients using our own collections of PDX and PDX-derived organoids
2022
·
Patricia Yagüe
, David Gomez
, et al.
·
Cancer Research
Abstract 2006: Comprehensive multiparametric analysis of non-small cell lung cancer describes novel genotype-immunophenotype relationships and provides putative biomarker signatures of response to checkpoint blockade
2020
·
Javier Ramos-Paradas
, David Gomez-Sanchez
, et al.
·
Cancer Research
Show more works
View as search
Works count:
17
Citation count:
64
H-index:
3
I10-index:
3
Year
Topic
Type